← Open Payments lookup

SARAH ROSPENDA: Open Payments

NPI 1407497340 · GOSHEN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,016 in 82 payments from 18 companies in 2025. Trend: 2023 $374 · 2024 $1,512 · 2025 $2,016

Food & beverage: $2,016
CompanyPaymentsAmount
Alkermes, Inc.14$318
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$295
ABBVIE INC.10$189
Teva Pharmaceuticals USA, Inc.8$178
Vanda Pharmaceuticals Inc.6$163
Corium, LLC3$150
Axsome Therapeutics, Inc.5$149
Boehringer Ingelheim Pharmaceuticals, Inc.1$94
Neurocrine BioSciences, Inc.5$92
Otsuka Pharmaceutical Development & Commercialization, Inc.1$70

Products named: CAPLYTA, ARISTADA, VRAYLAR, FANAPT, Azstarys, Auvelity, ABILIFY ASIMTUFII, AUSTEDO XR.

Industry payments across IN — which companies pay providers there.